Phase II trial of SDP 051 administered monthly
Latest Information Update: 07 Jul 2017
At a glance
- Drugs RG 6125 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 23 Jan 2014 New trial record
- 08 Jan 2014 This trial is expected to start in 2015, according to an Adheron Therapeutics media release.